Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Price Target at $90.79

The Cooper Companies, Inc. (NASDAQ:COO) has received an average rating of “Moderate Buy” from the seventeen analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $90.7857.

Several brokerages have recently commented on COO. Wells Fargo & Company increased their price target on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Friday, December 5th. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Piper Sandler reiterated an “overweight” rating and issued a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a report on Friday, December 5th. The Goldman Sachs Group reissued a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a research report on Friday, January 9th. Finally, Morgan Stanley raised their target price on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th.

Cooper Companies Price Performance

COO opened at $71.52 on Tuesday. The firm has a market capitalization of $13.95 billion, a P/E ratio of 35.41, a PEG ratio of 1.90 and a beta of 1.02. The stock has a fifty day moving average of $81.45 and a 200-day moving average of $75.97. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. Cooper Companies has a 12-month low of $61.78 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the firm earned $0.92 earnings per share. Cooper Companies’s quarterly revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In related news, Director Maria Rivas acquired 1,000 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was acquired at an average price of $82.13 per share, with a total value of $82,130.00. Following the completion of the transaction, the director owned 11,141 shares of the company’s stock, valued at approximately $915,010.33. This represents a 9.86% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Albert G. White III purchased 10,000 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was purchased at an average cost of $80.80 per share, with a total value of $808,000.00. Following the acquisition, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 16,014 shares of company stock worth $1,304,416 in the last quarter. 2.08% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors have recently added to or reduced their stakes in COO. Buckhead Capital Management LLC raised its stake in shares of Cooper Companies by 14.3% in the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock valued at $4,040,000 after acquiring an additional 7,368 shares during the last quarter. First American Bank bought a new stake in Cooper Companies during the 3rd quarter worth approximately $1,646,000. Rakuten Investment Management Inc. bought a new stake in Cooper Companies during the 3rd quarter worth approximately $11,341,000. Amundi increased its holdings in Cooper Companies by 35.5% during the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after purchasing an additional 348,652 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in Cooper Companies by 96.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after purchasing an additional 1,525,693 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.